Assessing Hims and Hers After Its 462% Multi Year Surge and Premium Valuation Multiple [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
This stock has quickly moved from niche telehealth play to mainstream market talking point. After a massive multi year climb culminating in a 461.9% gain over 3 years and 134.9% over 5 years, the shares have cooled off a bit, with a 37.6% gain year to date but modest pullbacks of 0.9% over the last week and 8.2% over the last month. Much of this move has been driven by growing enthusiasm around the company's direct to consumer model in areas like hair loss, mental health, and other recurring subscription based treatments. In these segments investors see a scalable, high margin growth runway. At the same time, debates about customer acquisition costs, competition in digital health, and how durable demand is over the long term have added nuance to the bullish story and helped fuel recent volatility. Right now Hims & Hers Health scores just on our valuation checks. In the next sections we will unpack what that actually means across different valuation methods and, by the end, explo
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- 3 Profitable Stocks for Long-Term Investors [Yahoo! Finance]Yahoo! Finance
- Hims stock falls after lawmakers propose GLP-1 compounding restrictions [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- Hims & Hers Brings Comprehensive Weight Loss Programme to the UKBusiness Wire
- What Analysts Think Is Changing the Hims and Hers Story for Long Term Investors [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/3/25 - Miss
HIMS
Sec Filings
- 12/23/25 - Form 4
- 12/22/25 - Form 144
- 12/18/25 - Form 4
- HIMS's page on the SEC website